Table 5 The association between alcohol drinking and head and neck cancer risk by the combination of ALDH2 rs671 and ADH1B rs1229984.
From: Investigating the Association between Alcohol and Risk of Head and Neck Cancer in Taiwan
Ethanol metabolism group | ||||||||
---|---|---|---|---|---|---|---|---|
Alcohol consumptiona | Group 1 Fast ADH1B (*2/*2) + Fast ALDH2 (*1/*1) | Group 2 Fast ADH1B (*2/*2) Slow/non-functional ALDH2 (*1/*2 + *2/*2) | Group 3 Slow ADH1B (*1/*1 + *1/*2) Fast ALDH2 (*1/*1) | Group 4 Slow ADH1B (*1/*1 + *1/*2) Slow/non-functional (*1/*2 + *2/*2) | ||||
 | Ca/Co | OR (95% CI)b | Ca/Co | OR (95% CI)b | Ca/Co | OR (95% CI)b | Ca/Co | OR (95% CI)b |
All head and neck cancer | ||||||||
Never + occasional | 44/84 | Referent | 109/180 | Referent | 27/68 | Referent | 71/169 | Referent |
Ever regular | 131/165 | 0.57 (0.31–1.03) | 121/55 | 2.16 (1.34–3.48) | 123/130 | 1.50 (0.74–3.04) | 156/64 | 4.26 (2.68–6.78) |
 | P-interaction < 0.0001 | |||||||
Never | 37/70 | Referent | 103/162 | Referent | 21/51 | Referent | 65/156 | Referent |
Monthly | 7/14 | 0.93 (0.31–2.83) | 6/18 | 0.60 (0.20–1.79) | 6/17 | 1.29 (0.36–4.63) | 6/13 | 1.66 (0.56–4.93) |
Weekly | 24/49 | 0.49 (0.22–1.08) | 21/19 | 1.51 (0.70–3.28) | 19/35 | 1.67 (0.63–4.42) | 18/22 | 2.43 (1.12–5.26) |
Daily | 101/116 | 0.56 (0.29–1.10) | 98/33 | 2.51 (1.45–4.32) | 98/93 | 1.56 (0.66–3.71) | 134/41 | 5.27 (3.15–8.85) |
Unknown | 6/0 | — | 2/3 | — | 6/2 | — | 4/1 | — |
 | P-interaction < 0.0001c | |||||||
Never | 37/68 | Referent | 101/153 | Referent | 18/49 | Referent | 54/150 | Referent |
Light | 29/66 | 0.52 (0.25–1.09) | 27/35 | 1.16 (0.60–2.24) | 20/54 | 1.04 (0.39–2.77) | 26/32 | 2.50 (1.26–4.97) |
Moderate | 24/43 | 0.58 (0.26–1.27) | 25/11 | 1.38 (0.59–3.24) | 30/34 | 1.86 (0.69–5.07) | 30/14 | 4.17 (1.90–9.15) |
Heavy | 62/54 | 0.65 (0.30–1.39) | 61/16 | 2.74 (1.37–5.51) | 59/39 | 2.14 (0.79–5.75) | 87/20 | 8.22 (4.31–15.67) |
Unknown | 7/0 | — | 2/4 | — | 6/4 | — | 3/2 | — |
 | P-interaction < 0.0001c | |||||||
Every 10 grams/day |  | 1.01 (0.98–1.03) |  | 1.05 (0.99–1.11) |  | 1.05 (1.00–1.10) |  | 1.13 (1.07–1.19) |
 | P-interaction = 0.002 | |||||||
Oral cavity | ||||||||
Never + occasional | 29/84 | Referent | 84/180 | Referent | 26/68 | Referent | 52/169 | Referent |
Ever regular | 91/165 | 0.59 (0.29–1.23) | 65/55 | 1.40 (0.81–2.41) | 82/130 | 0.83 (0.37–1.87) | 72/64 | 2.42 (1.43–4.09) |
 | P-interaction = 0.004 | |||||||
Never | 27/70 | Referent | 81/162 | Referent | 20/51 | Referent | 46/156 | Referent |
Monthly | 2/14 | 0.38 (0.07–2.05) | 3/18 | 0.34 (0.08–1.41) | 6/17 | 1.24 (0.32–4.84) | 6/13 | 2.32 (0.75–7.07) |
Weekly | 16/49 | 0.43 (0.17–1.10) | 14/19 | 1.25 (0.50–3.10) | 12/35 | 0.91 (0.28–2.94) | 7/22 | 1.17 (0.42–3.27) |
Daily | 70/116 | 0.50 (0.22–1.13) | 49/33 | 1.41 (0.76–2.62) | 64/93 | 0.81 (0.30–2.20) | 63/41 | 3.11 (1.74–5.54) |
Unknown | 5/0 | — | 2/3 | — | 6/2 | — | 2/1 | — |
 | P-interaction = 0.005c | |||||||
Never | 27/68 | Referent | 79/153 | Referent | 17/49 | Referent | 38/150 | Referent |
Light | 21/66 | 0.43 (0.18–1.03) | 18/35 | 1.04 (0.48–2.23) | 14/54 | 0.55 (0.17–1.83) | 14/32 | 1.65 (0.72–3.77) |
Moderate | 17/43 | 0.52 (0.20–1.33) | 12/11 | 0.78 (0.29–2.08) | 20/34 | 0.85 (0.25–2.90) | 17/14 | 3.25 (1.35–7.82) |
Heavy | 40/54 | 0.49 (0.19–1.23) | 31/16 | 1.51 (0.69–3.27) | 35/39 | 0.71 (0.22–2.32) | 35/20 | 4.11 (1.98–8.54) |
Unknown | 6/0 | — | 2/4 | — | 6/4 | — | 1/2 | — |
 | P-interaction = 0.01c | |||||||
Every 10 grams/day |  | 1.00 (0.97–1.03) |  | 1.01 (0.97–1.06) |  | 1.02 (0.97–1.07) |  | 1.08 (1.03–1.14) |
 | P-interaction = 0.11 | |||||||
Oropharynx | ||||||||
Never + occasional | 5/84 | Referent | 10/180 | Referent | 1/68 | Referent | 8/169 | Referent |
Ever regular | 16/165 | 1.02 (0.24–4.34) | 23/55 | 6.69 (2.38–18.86) | 16/130 | 18.50 (1.43–240.03) | 29/64 | 9.49 (3.22–27.93) |
 | P-interaction = 0.14 | |||||||
Never | 3/70 | Referent | 9/162 | Referent | 1/51 | Referent | 8/156 | Referent |
Monthly | 2/14 | 4.76 (0.57–39.96) | 1/18 | 1.35 (0.15–12.61) | 0/17 | — | 0/13 | — |
Weekly | 3/49 | 1.68 (0.22–12.50) | 2/19 | 2.58 (0.43–15.46) | 5/35 | 16.11 (1.11–233.63) | 3/22 | 2.73 (0.48–15.62) |
Daily | 12/116 | 1.76 (0.29–10.77) | 21/33 | 9.51 (3.10–29.22) | 11/93 | 14.54 (0.94–224.84) | 25/41 | 11.96 (3.74–38.31) |
Unknown | 1/0 | — | 0/3 | — | 0/2 | — | 1/1 | — |
 | P-interaction = 0.52c | |||||||
Never | 3/68 | Referent | 9/153 | Referent | 1/49 | Referent | 6/150 | Referent |
Light | 3/66 | 1.57 (0.21–11.73) | 2/35 | 1.29 (0.24–7.02) | 4/54 | 8.68 (0.60–125.25) | 4/32 | 5.23 (0.95–28.73) |
Moderate | 4/43 | 4.49 (0.58–34.60) | 5/11 | 5.80 (1.25–27.04) | 5/34 | 23.89 (1.66–344.63) | 3/14 | 5.66 (0.91–35.09) |
Heavy | 7/54 | 3.38 (0.40–28.57) | 16/16 | 15.23 (4.17–55.60) | 7/39 | 21.50 (1.34–346.11) | 21/20 | 32.10 (7.64–134.95) |
Unknown | 1/0 | — | 0/4 | — | 0/4 | — | 1/2 | — |
 | P-interaction = 0.48c | |||||||
Every 10 grams/day |  | 1.02 (0.95–1.10) |  | 1.12 (1.03–1.22) |  | 1.09 (0.99–1.21) |  | 1.13 (1.05–1.22) |
 | P-interaction = 0.06 | |||||||
Hypopharynx | ||||||||
Never + occasional | 2/84 | Referent | 2/180 | Referent | 0/68 | Referent | 0/169 | Referent |
Ever regular | 10/165 | 0.35 (0.04–3.07) | 21/55 | 39.04 (7.53–202.44) | 12/130 | — | 41/64 | — |
 | P-interaction = d | |||||||
Never | 2/70 | Referent | 2/162 | Referent | 0/51 | Referent | 0/156 | Referent |
Monthly | 0/14 | — | 0/18 | — | 0/17 | — | 0/13 | — |
Weekly | 3/49 | 0.70 (0.06–8.48) | 3/19 | 20.30 (2.60–158.68) | 0/35 | — | 6/22 | — |
Daily | 7/116 | 0.22 (0.02–2.21) | 18/33 | 44.00 (7.93–244.10) | 12/93 | — | 35/41 | — |
Unknown | 0/0 | — | 0/3 | — | 0/0 | — | 0/1 | — |
 | P-interaction = d | |||||||
Never | 2/68 | Referent | 2/153 | Referent | 0/49 | Referent | 0/150 | Referent |
Light | 2/66 | 0.22 (0.02–3.07) | 3/35 | 5.96 (0.82–43.62) | 0/54 | — | 7/32 | — |
Moderate | 1/43 | 0.13 (0.01–2.92) | 6/11 | 63.16 (6.58–606.45) | 3/34 | — | 9/14 | — |
Heavy | 6/54 | 0.62 (0.06–6.52) | 7/16 | 51.30 (5.59–470.69) | 9/39 | — | 21/20 | — |
Unknown | 0/0 | — | 0/4 | — | 0/4 | — | 0/2 | — |
 | P-interaction = d | |||||||
Every 10 grams/day |  | 1.04 (0.98–1.11) |  | 1.10 (1.00–1.21) |  | 1.13 (1.01–1.26) |  | 1.15 (1.06–1.24) |
 | P-interaction = 0.07 | |||||||
Larynx | ||||||||
Never + occasional | 8/84 | Referent | 13/180 | Referent | 0/68 | Referent | 11/169 | Referent |
Ever regular | 14/165 | 0.21 (0.06–0.77) | 12/55 | 2.01 (0.73–5.56) | 13/130 | — | 14/64 | 4.49 (1.58–12.76) |
 | P-interaction = d | |||||||
Never | 5/70 | Referent | 11/162 | Referent | 0/51 | Referent | 11/156 | Referent |
Monthly | 3/14 | 3.41 (0.34–34.53) | 2/18 | 2.45 (0.46–13.17) | 0/17 | — | 0/13 | — |
Weekly | 2/49 | 0.13 (0.02–1.08) | 2/19 | 1.93 (0.35–10.68) | 2/35 | — | 2/22 | 2.09 (0.36–12.27) |
Daily | 12/116 | 0.38 (0.09–1.73) | 10/33 | 2.68 (0.84–8.51) | 11/93 | — | 11/41 | 5.40 (1.68–17.36) |
Unknown | 0/0 | — | 0/3 | — | 0/2 | — | 1/1 | — |
 | P-interaction = d | |||||||
Never | 5/68 | Referent | 11/153 | Referent | 0/49 | Referent | 10/150 | Referent |
Light | 3/66 | 0.22 (0.03–1.45) | 4/35 | 1.95 (0.52–7.26) | 2/54 | — | 1/32 | 0.80 (0.08–7.56) |
Moderate | 2/43 | 0.12 (0.01–1.07) | 2/11 | 1.25 (0.18–8.69) | 2/34 | — | 1/14 | 1.54 (0.12–20.02) |
Heavy | 9/54 | 1.06 (0.20–5.69) | 7/16 | 3.46 (0.89–13.42) | 8/39 | — | 10/20 | 11.84 (2.88–48.63) |
Unknown | 0/0 | — | 0/4 | — | 0/4 | — | 1/2 | — |
 | P-interaction = d | |||||||
Every 10 grams/day |  | 1.03 (0.98–1.08) |  | 1.02 (0.93–1.12) |  | 1.13 (1.03–1.23) |  | 1.13 (1.04–1.22) |
 | P-interaction = 0.16 |